AaviGen, SK pharmteco Announce Manufacturing Agreement for Heart Failure Gene Therapy
SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product. The California-based contract development and manufacturing organization (CDMO) SK pharmteco, which focuses on small molecules and advanced therapies …